法洛四联症修复术后成人肺动脉瓣置换的短期与中期心室重构
本研究前瞻性纳入74例在Bambino Gesù儿童医院接受外科肺动脉瓣置换(PVR)的法洛四联症修复术后(rTOF)成人,术前、术后6个月及中位57个月随访时行心脏磁共振(CMR)和心肺运动试验(CPET)。PVR后右心室(RV)逆重构持续存在,收缩功能改善,双心室耦联增强;术前RVESVi≤68.5 mL/m2者RV正常化机会最佳。
要点
- PVR后RVEDVi和RVESVi立即下降并持续至中期随访,RVEF改善。
- 术前RVEDVi≤157.5 mL/m2和RVESVi≤68.5 mL/m2是RV正常化的ROC阈值。
- 术前RV与LV容积强相关,术后出现RVEF与LVEF新相关,提示双心室耦联增强。
核心结论
- PVR导致立即且持续的RV逆重构,收缩功能改善并强化双心室耦联。
- 在RVESVi超过68.5 mL/m2之前早期干预,提供RV正常化的最佳机会。
- 整合CMR与CPET提供多参数策略以优化rTOF的时机、患者选择和长期随访。
研究设计与样本
- 前瞻性队列研究,纳入74例在Bambino Gesù儿童医院接受外科PVR的rTOF患者。
- 初次修复平均年龄0.8岁,PVR时平均年龄17.2岁;平均体表面积1.74 m2。
- 术前、术后6个月及中位57个月随访时行CMR和CPET;用ANOVA评估形态功能变化,ROC曲线确定RV正常化阈值。
主要发现
- RVEDVi从166.8 ± 30.1 mL/m2(95%CI 162.5-171.1)降至术后121.1 ± 22.4 mL/m2(95%CI 117.0-125.2),随访时130.2 ± 23.5 mL/m2(95%CI 126.1-134.3)。
- RVESVi从85.7 ± 21.5 mL/m2(95%CI 81.2-90.2)降至56.1 ± 14.9 mL/m2(95%CI 52.6-59.6),随访时61.9 ± 16.3 mL/m2(95%CI 58.1-65.7)。
- RVEF从49.2%(95%CI 47.3-51.1)改善至55.6%(95%CI 53.6-57.6)。
- 术前RV与LV容积强相关(r=0.79,P < .001)持续至术后,术后出现RVEF与LVEF新相关(r=0.65,P < .001)。
关键数值与推荐
- ROC分析确定术前RVEDVi≤157.5 mL/m2(AUC 0.871,95%CI 0.76-0.98)和RVESVi≤68.5 mL/m2(AUC 0.822,95%CI 0.71-0.92)为RV正常化阈值。
临床怎么用
- 对rTOF成人行PVR决策时,可参考术前RVEDVi≤157.5 mL/m2和RVESVi≤68.5 mL/m2阈值,在RVESVi超过68.5 mL/m2前干预以争取RV正常化。
- 整合CMR与CPET进行多参数评估,优化PVR时机、患者选择和长期随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Pulmonary valve replacement (PVR) in patients with repaired tetralogy of Fallot (rTOF) is performed to preserve right ventricular (RV) function and improve exercise capacity. The effects of PVR extend beyond the RV, influencing left ventricular (LV) performance through biventricular interdependence. This study aimed to evaluate the rate of structural and functional ventricular adaptation after PVR, with a focus on risk stratification and clinical management. METHODS: We prospectively enrolled 74 patients with rTOF who underwent surgical PVR at Bambino Gesù Paediatric Hospital. The mean age at initial repair was 0.8 years and at PVR 17.2 years; mean body surface area 1.74 m2. Cardiovascular magnetic resonance (CMR) and cardiopulmonary exercise testing (CPET) were performed preoperatively, 6 months after surgery, and at midterm follow-up (median 57 months). Morphological and functional changes were assessed with ANOVA, and correlations between ventricular parameters were analysed. Receiver-operating-characteristic (ROC) curves identified thresholds for RV normalization. RESULTS: Indexed RV end-diastolic volume (RVEDVi) decreased from 166.8 ± 30.1 mL/m2 (95% confidence interval [CI] 162.5-171.1) to 121.1 ± 22.4 mL/m2 (95% CI 117.0-125.2) postoperatively and 130.2 ± 23.5 mL/m2 (95% CI 126.1-134.3) at follow-up. Indexed RV end-systolic volume (RVESVi) decreased from 85.7 ± 21.5 mL/m2 (95% CI 81.2-90.2) to 56.1 ± 14.9 mL/m2 (95% CI 52.6-59.6) and 61.9 ± 16.3 mL/m2 (95% CI 58.1-65.7). RV ejection fraction improved from 49.2% (95% CI 47.3-51.1) to 55.6% (95% CI 53.6-57.6). ROC analysis identified pre-operative cut-offs RVEDVi ≤ 157.5 mL/m2 and RVESVi ≤ 68.5 mL/m2 for RV normalization (AUC 0.871 [95% CI 0.76-0.98]; 0.822 [95% CI 0.71-0.92]). Strong pre-operative correlations between RV and LV volumes (r = 0.79, P < .001) persisted post-operatively, with a new correlation between right ventricular ejection fraction [RVEF] and left ventricular ejection fraction [LVEF] (r = 0.65, P < .001). CONCLUSIONS: PVR leads to immediate and sustained RV reverse remodelling, with improved systolic function and reinforced biventricular coupling. Early intervention-before RVESVi exceeds 68.5 mL/m2-offers the best chance for RV normalization. Integrating CMR with CPET provides a multiparametric strategy to optimize timing, patient selection, and long-term follow-up in rTOF.
引用
- Brancaccio G, Letizia A, Verrengia M, et al. Short- and Mid-term Cardiac Ventricular Remodelling After Pulmonary Valve Replacement in Adults With Repaired Tetralogy of Fallot. Eur J Cardiothorac Surg. 2025. PMID: 41330693. doi:10.1093/ejcts/ezaf432
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。